Drug-price Transparency for Consumers Act of 2023

3.0.0 1250 2025-12-05T08:59:35Z 2025-12-05T08:59:35Z Senate S S 2023-04-20 118 https://www.congress.gov/bill/118th-congress/senate-bill/1250 ssfi00 Finance Committee Senate Standing Referred To 2023-04-20T18:37:02Z Drug-price Transparency for Consumers Act of 2023 118 5958 HR 2024-12-17 Referred to the Subcommittee on Health. Identical bill CRS 2023-04-20 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298) IntroReferral 2023-04-20 Introduced in Senate IntroReferral 10000 9 Library of Congress D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. N G000386 Sen. Grassley, Chuck [R-IA] Chuck Grassley R IA 2023-04-20 True K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2023-04-20 True B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2023-04-20 True B001277 Sen. Blumenthal, Richard [D-CT] Richard Blumenthal D CT 2023-04-20 True V000137 Sen. Vance, J. D. [R-OH] J. Vance R OH D. 2023-04-20 True B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI 2023-04-20 True B000944 Sen. Brown, Sherrod [D-OH] Sherrod Brown D OH 2023-07-12 False S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2023-09-07 False Health Administrative law and regulatory procedures 2025-03-21T20:05:44Z Civil actions and liability 2025-03-21T20:05:44Z Department of Health and Human Services 2025-03-21T20:05:44Z Health care costs and insurance 2025-03-21T20:05:44Z Marketing and advertising 2025-03-21T20:05:44Z Prescription drugs 2025-03-21T20:05:44Z Health 2023-05-09T12:15:20Z

00 2023-04-20 Introduced in Senate 2024-03-27T14:55:23Z Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023 This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Drug-price Transparency for Consumers Act of 2023 Display Title 45 Drug-price Transparency for Consumers Act of 2023 2024-07-24T15:22:32Z Short Title(s) as Introduced 101 Drug-price Transparency for Consumers Act of 2023 2024-05-24T13:40:37Z Introduced in Senate IS Official Title as Introduced 6 A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information. 2024-03-29T08:08:26Z Introduced in Senate IS Introduced in Senate 2023-04-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s1250is/xml/BILLS-118s1250is.xml 2023-04-20 Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.